Diagnostic Nuclear Drug Market

Nuclear Drugs are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the?diagnosis
Diagnostic Nuclear Drug Market aims to provide a comprehensive presentation of the global market for Diagnostic Nuclear Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Nuclear Drug. Diagnostic Nuclear Drug Market contains market size and forecasts of Diagnostic Nuclear Drug in global, including the following market information:
Global Diagnostic Nuclear Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Diagnostic Nuclear Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tc-99m Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diagnostic Nuclear Drug include Bracco Imaging, Bayer, Curium Pharmaceuticals, Nordion, Triad Isotopes, Lantheus, GE Healthcare, China Isotope & Radiation and Jubilant Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diagnostic Nuclear Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diagnostic Nuclear Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Diagnostic Nuclear Drug Market Segment Percentages, by Type, 2022 (%)
Tc-99m
F-18
Other
Global Diagnostic Nuclear Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Diagnostic Nuclear Drug Market Segment Percentages, by Application, 2022 (%)
Oncology
Cardiology
Other
Global Diagnostic Nuclear Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Diagnostic Nuclear Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diagnostic Nuclear Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diagnostic Nuclear Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diagnostic Nuclear Drug, market overview.
Chapter 2: Global Diagnostic Nuclear Drug market size in revenue.
Chapter 3: Detailed analysis of Diagnostic Nuclear Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diagnostic Nuclear Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.